Ardent Health, Inc. (NYSE:ARDT) Given Consensus Rating of "Hold" by Brokerages

Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has received a consensus recommendation of "Hold" from the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $13.0455.

ARDT has been the subject of several research reports. The Goldman Sachs Group reaffirmed a "neutral" rating and set a $13.00 price objective on shares of Ardent Health in a report on Thursday, August 6th. Guggenheim boosted their price objective on shares of Ardent Health from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Thursday, August 6th. Truist Financial raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Wall Street Zen downgraded shares of Ardent Health from a "buy" rating to a "hold" rating in a report on Sunday, July 12th. Finally, Zacks Research cut shares of Ardent Health from a "hold" rating to a "strong sell" rating in a research note on Thursday, August 6th.

Ardent Health Stock Down 1.0%

Shares of NYSE ARDT opened at $10.85 on Tuesday. The stock has a market capitalization of $1.53 billion, a price-to-earnings ratio of 19.73, a price-to-earnings-growth ratio of 3.07 and a beta of 0.70. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The firm has a 50-day moving average price of $10.59 and a 200 day moving average price of $9.78. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities research analysts anticipate that Ardent Health will post 0.97 EPS for the current fiscal year.

Insider Activity at Ardent Health

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of the business's stock in a transaction dated Friday, June 5th. The stock was acquired at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the transaction, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. This represents a 3.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ardent Health

A number of hedge funds and other institutional investors have recently made changes to their positions in ARDT. BlackRock Inc. purchased a new position in Ardent Health during the second quarter worth about $21,415,000. Goldentree Asset Management LP lifted its holdings in shares of Ardent Health by 99.7% during the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company's stock worth $20,302,000 after acquiring an additional 1,150,000 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after acquiring an additional 724,841 shares during the last quarter. Ameriprise Financial Inc. increased its position in Ardent Health by 75.6% during the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company's stock worth $22,332,000 after purchasing an additional 703,739 shares during the last quarter. Finally, Algert Global LLC raised its stake in Ardent Health by 1,277.3% during the second quarter. Algert Global LLC now owns 597,745 shares of the company's stock worth $5,882,000 after purchasing an additional 554,345 shares during the period.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source